| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Innoviva, Inc. | Director | Common Stock | 44.1K | $711K | $16.13 | Jun 17, 2024 | Direct |
| Nuvalent, Inc. | Director | Class A Common Stock | 5.15K | $343K | $66.72 | Jun 18, 2025 | Direct |
| Aura Biosciences, Inc. | Director | Common Stock | 23.5K | $126K | $5.35 | Jun 17, 2025 | Direct |
| Tourmaline Bio, Inc. | Director | Common Stock | 0 | $0 | $47.83 | Oct 28, 2025 | Direct |
| ALUMIS INC. | Director | Stock Option (Right to Buy) | 49.8K | Jul 30, 2025 | Direct | ||
| SQZ Biotechnologies Co | Director | Stock Option | 39.9K | Jun 14, 2023 | Direct | ||
| Innoviva, Inc. | Director | Non-statutory Stock Option | 22.5K | Jun 17, 2024 | Direct | ||
| Aura Biosciences, Inc. | Director | Stock Option (Right to Buy) | 17K | Jun 17, 2025 | Direct | ||
| Tourmaline Bio, Inc. | Director | Stock Option (Right to Buy) | 16.8K | Jun 4, 2025 | Direct | ||
| Nuvalent, Inc. | Director | Stock Option (Right to Buy) | 4.15K | Jun 18, 2025 | Direct | ||
| Tourmaline Bio, Inc. | Director | Employee Stock Option (Right to Buy) | 0 | Oct 28, 2025 | Direct |